A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

NCT02567578 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped Technology transfer

Conditions

Functional Dyspepsia

Interventions

DRUG: YH12852 0.1 mg
DRUG: YH12852 0.25 mg
DRUG: YH12852 0.5 mg
DRUG: Placebo

Sponsor

Yuhan Corporation